Palatin Technologies
PTN
#9833
Rank
โ‚ฌ39.5 M
Marketcap
23,20ย โ‚ฌ
Share price
10.46%
Change (1 day)
2,639.26%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -โ‚ฌ15.7 Million

According to Palatin Technologies's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ22.94 Million, an increase over its 2023 earnings that were of -โ‚ฌ27.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ15.7 Million-31.56%
2024 -โ‚ฌ22.94 Million-16.9%
2023 -โ‚ฌ27.61 Million5.99%
2022 -โ‚ฌ26.05 Million-13.7%
2021 -โ‚ฌ30.18 Million33.25%
2020 -โ‚ฌ22.65 Million-172.11%
2019 โ‚ฌ31.4 M2352.33%
2018 โ‚ฌ1.28 M-94.13%
2017 โ‚ฌ21.82 M-154.92%
2016 -โ‚ฌ39.74 Million3.67%
2015 -โ‚ฌ38.33 Million878%
2014 -โ‚ฌ3.92 Million-72.64%
2013 -โ‚ฌ14.33 Million-33.11%
2012 -โ‚ฌ21.42 Million77.71%
2011 -โ‚ฌ12.05 Million
2003 -โ‚ฌ20.41 Million29.93%
2002 -โ‚ฌ15.71 Million36.18%
2001 -โ‚ฌ11.54 Million
1999 -โ‚ฌ9.58 Million6.04%
1998 -โ‚ฌ9.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-โ‚ฌ10.06 Million-31.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚ฌ25.11 Million 70.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ0.49 B-3,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚ฌ43.04 M-392.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ56.87 M-486.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚ฌ0.11 Billion 580.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ27.58 B-187,443.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚ฌ47.31 Million 221.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ11.14 B-75,798.43%๐Ÿ‡ฌ๐Ÿ‡ง UK